Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune thyroiditis promotes breast cancer progression: exploratory role of thyroid hormone receptor beta signaling disruption. | Breast Cancer Res | 2025 | 41287065 | PubTator, text mining | PubMed |
| Novel Thyroid Hormone Receptor β Gene Variant (F245L) Causing Mild Resistance to Thyroid Hormone. | JCEM Case Rep | 2025 | 41267806 | PubTator, text mining | PubMed |
| Identifying SUMOylation-related genes in liver fibrosis with bioinformatics and experimental models for diagnostic insights. | Sci Rep | 2025 | 41233500 | PubTator, text mining | PubMed |
| Using Machine Learning for the Discovery and Development of Multitarget Flavonoid-Based Functional Products in MASLD. | Molecules | 2025 | 41226123 | PubTator, text mining | PubMed |
| Resistance to thyroid hormone: clinical and biochemical paradox. | BMJ Case Rep | 2025 | 41192965 | PubTator, text mining | PubMed |
| Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials. | Arch Pharm Res | 2025 | 41166060 | PubTator, text mining | PubMed |
| Resistance to Thyroid Hormone Beta and Coexisting Thyroid Disease: Diagnostic and Therapeutic Challenges Illustrated by Two Cases. | Case Rep Endocrinol | 2025 | 41163645 | PubTator, text mining | PubMed |
| Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutation. | Eur Thyroid J | 2025 | 41159509 | PubTator, text mining | PubMed |
| Mutation of the Thyroid Hormone Receptor Beta Gene (THRB) Causes Vitelliform Macular Dystrophy with High Intrafamilial Variability. | Genes (Basel) | 2025 | 41153457 | PubTator, text mining | PubMed |
| Editorial: Opportunities and challenges in drug repurposing. | Front Pharmacol | 2025 | 41132545 | PubTator, text mining | PubMed |
| Thyroid Hormone Receptor β Suppresses Cancer Cell Activity by Differential Regulation of Glycogen Metabolism. | Endocrinology | 2025 | 41129693 | PubTator, text mining | PubMed |
| Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease. | Endocrine | 2025 | 41129062 | PubTator, text mining | PubMed |
| ECM remodeling in hypothyroidism-associated MAFLD: mechanisms, clinical relevance, and therapeutic targets. | Front Immunol | 2025 | 41112248 | PubTator, text mining | PubMed |
| From steatosis to cirrhosis: the role of obesity in the progression of liver disease. | J Diabetes Metab Disord | 2025 | 41104308 | PubTator, text mining | PubMed |
| Steatotic liver disease and cancer: from pathogenesis to therapeutic targets. | eGastroenterology | 2025 | 41098801 | PubTator, text mining | PubMed |
| Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth. | Mol Cancer | 2025 | 41088246 | PubTator, text mining | PubMed |
| Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease. | Curr Opin Endocrinol Diabetes Obes | 2025 | 41076573 | PubTator, text mining | PubMed |
Discovery of the Insecticide Chlorantraniliprole as a Thyroid Hormone Receptor β Antagonist Reinforcing Thyroid-Liver Metabolic Disruption to Promote Metabolic Dysfunction-Associated Steatotic Liver Disease. | Environ Sci Technol | 2025 | 41071855 | PubTator, text mining | PubMed |
| Resistance to Thyroid Hormone in Crohn's Disease: A Clinical Challenge of Refractory Thyroid Stimulating Hormone Elevation and Therapeutic Dilemmas. | Clin Case Rep | 2025 | 41018991 | PubTator, text mining | PubMed |
| Structure-based design of novel THR-β agonists and mechanism of activation research by molecular dynamics simulations. | Bioorg Med Chem | 2025 | 41014899 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=8